Please enable JS

ARTICLES & TESTIMONIALS

Houston Chronicle – Soaring specialty drug prices leave patients seeking relief

Mar 23/50SN Staff/ Advocates in the news GHLF in the news

Julie Wiles of Spring says she found relief from rheumatoid arthritis when she began receiving injections of Enbrel, a drug that costs $2,500 a week. But even with insurance coverage, Wiles can no longer afford Enbrel. Instead, she takes a combination of less expensive drugs and injections that hasn’t been nearly as effective.   Read […]

READ MORE

The Washington Post – Biologics are revolutionizing care for some diseases, but they are very costly

Mar 23/50SN Staff/ Advocates in the news

Mariah Leach felt at the top of her game six years ago. At age 25, she was pursuing a law degree and a master’s in environmental policy at the University of Colorado, earning straight A’s and playing water polo with the university’s club team. But then her toes began to hurt. A few weeks, later […]

READ MORE

Oregon House of Representatives Committee on Health Care

Mar 16/50SN Staff/ Letters and Testimony

TESTIMONY – STATE BIOSIMILAR SUBSTITUTION Oregon House of Representatives Committee on Health Care  Committee on Health Care consideration of HB 2026  Speaker: Anna Marie Meyer Patient Advocate Global Healthy Living Foundation March 16, 2015 Disclosure: I have no disclosures to make regarding my travel here today. The Global Healthy Living Foundation accepts grants and charitable contributions […]

READ MORE

Medical Marketing & Media – Biosimilar uptake will require companies to tell a trustworthy backstory

Mar 12/50SN Staff/ GHLF in the news

Novartis still has to win a patent-infringement lawsuit before it can sell Zarxio, the first biosimilar to receive FDA approval, but experts and advocates indicate the potential rollout of the drug is less important than the fact that the approval has smoothed the way for the four biosimilar applications in front of the FDA. Read […]

READ MORE

International Business Times – Generic Biologics? After FDA Approves First Biosimilar Drug, Education, Clearer Policies Needed, Experts Say

Mar 11/50SN Staff/ Advocates in the news GHLF in the news

Last year, when Mariah Leach was pregnant with her son, her rheumatoid arthritis flared up again. She had stopped medication during pregnancy, but when the autoimmune disease, which causes painful and damaging inflammation in joints and elsewhere, resurged, she and her doctors made the difficult decision for her to restart during her third trimester, based […]

READ MORE